This past March, Gardner Denver agreed to sell itself to the storied buyout boutique for $76 per share. That engendered a degree of controversy from Wall Street, as some valuations put the company's value much higher. Thomson Reuters StarMine unit pegged it at nearly $85.50.
That $76-per-share price values the company at around $3.9 billion. Current Gardner Denver shareholders will receive that amount in cash in exchange for their stock. The transaction is expected to be completed later this month or in August.
At the moment, Gardner Denver has roughly 49.2 million shares outstanding. Its stock most recently closed at $75.90.
Fool contributor Eric Volkman and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Salix Pharma Moves to S&P MidCap 400; Agree Realty and DXP to Join SmallCap 600
The drugmaker will advance to a higher index, while Agree Realty and DXP are to be included on the smaller-firm list.
Why Gardner Denver's Earnings May Be Less Than Awesome
Don't just count the cash, time it.
Gardner Denver Keeps Dividend Steady
The company will pay the same amount it's been doling out since late 2009.